4//SEC Filing
MacFarlane Katie 4
Accession 0001493152-20-018822
CIK 0000849636other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 3:50 PM ET
Size
5.3 KB
Accession
0001493152-20-018822
Insider Transaction Report
Form 4
MacFarlane Katie
Director
Transactions
- Award
Common Stock Options (to purchase shares of Common Stock)
2020-09-30+5,000,000→ 5,000,000 totalExercise: $0.01Exp: 2025-09-30→ Common Stock (5,000,000 underlying)
Footnotes (1)
- [F1]These Common Stock Options vested upon issuance.
Documents
Issuer
RespireRx Pharmaceuticals Inc.
CIK 0000849636
Entity typeother
Related Parties
1- filerCIK 0001608535
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 3:50 PM ET
- Size
- 5.3 KB